Walleye Trading LLC Cytokinetics Inc Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $1.11 Million - $3.45 Million	41,269 New	41,269 $3.45 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $491,452 - $613,939	15,066 New	15,066 $491,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $198,523 - $283,660	5,550 Added 93.06%	11,514 $527,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $229,852 - $325,157	5,964 New	5,964 $289,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $182,799 - $342,719	-11,979 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $38,669 - $54,415	1,879 Added 18.6%	11,979 $259,000
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $60,095 - $102,919	10,100 New	10,100 $82,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.